Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1979 Jul;32(7):639–650. doi: 10.1136/jcp.32.7.639

Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.

N E Miller
PMCID: PMC1145769  PMID: 227940

Full text

PDF
639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagdade J., Casaretto A., Albers J. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man. J Lab Clin Med. 1976 Jan;87(1):38–48. [PubMed] [Google Scholar]
  2. Bolzano K., Krempler F., Sandhofer F. Hepatic and extrahepatic triglyceride lipase activity in uraemic patients on chronic haemodialysis. Eur J Clin Invest. 1978 Oct;8(5):289–293. doi: 10.1111/j.1365-2362.1978.tb00844.x. [DOI] [PubMed] [Google Scholar]
  3. Bradby G. V., Valente A. J., Walton K. W. Serum high-density lipoproteins in peripheral vascular disease. Lancet. 1978 Dec 16;2(8103):1271–1274. doi: 10.1016/s0140-6736(78)92038-x. [DOI] [PubMed] [Google Scholar]
  4. Bradley D. D., Wingerd J., Petitti D. B., Krauss R. M., Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med. 1978 Jul 6;299(1):17–20. doi: 10.1056/NEJM197807062990104. [DOI] [PubMed] [Google Scholar]
  5. Breckenridge W. C., Little J. A., Steiner G., Chow A., Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med. 1978 Jun 8;298(23):1265–1273. doi: 10.1056/NEJM197806082982301. [DOI] [PubMed] [Google Scholar]
  6. Brunzell J. D., Hazzard W. R., Porte D., Jr, Bierman E. L. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 1973 Jul;52(7):1578–1585. doi: 10.1172/JCI107334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brunzell J. D., Schrott H. G., Motulsky A. G., Bierman E. L. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism. 1976 Mar;25(3):313–320. doi: 10.1016/0026-0495(76)90089-5. [DOI] [PubMed] [Google Scholar]
  8. Brunzell J. D., Schrott H. G. The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis. Trans Assoc Am Physicians. 1973;86:245–254. [PubMed] [Google Scholar]
  9. Carlson L. A., Kolmodin-Hedman B. Hyper- -lipoproteinemia in men exposed to chlorinated hydrocarbon pesticides. Acta Med Scand. 1972 Jul-Aug;192(1-2):29–32. doi: 10.1111/j.0954-6820.1972.tb04773.x. [DOI] [PubMed] [Google Scholar]
  10. Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A., Zukel W. J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977 May;55(5):767–772. doi: 10.1161/01.cir.55.5.767. [DOI] [PubMed] [Google Scholar]
  11. Chait A., Brunzell J. D., Albers J. J., Hazzard W. R. Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism. Lancet. 1977 Jun 4;1(8023):1176–1178. doi: 10.1016/s0140-6736(77)92717-9. [DOI] [PubMed] [Google Scholar]
  12. Clifton-Bligh P., Nestel P. J., Whyte H. M. Tangier disease. Report of a case and studies of lipid metabolism. N Engl J Med. 1972 Mar 16;286(11):567–571. doi: 10.1056/NEJM197203162861103. [DOI] [PubMed] [Google Scholar]
  13. Cramp D. G., Tickner T. R., Beale D. J., Moorhead J. F., Wills M. R. Plasma triglyceride secretion and metabolism in chronic renal failure. Clin Chim Acta. 1977 Apr 15;76(2):237–241. doi: 10.1016/0009-8981(77)90102-4. [DOI] [PubMed] [Google Scholar]
  14. Drevon C. A., Berg T., Norum K. R. Uptake and degradation of cholesterol ester-labelled rat plasma lipoproteins in purified rat hepatocytes and nonparenchymal liver cells. Biochim Biophys Acta. 1977 Apr 26;487(1):122–136. doi: 10.1016/0005-2760(77)90049-2. [DOI] [PubMed] [Google Scholar]
  15. Enger S. C., Hjermann I., Foss O. P., Helgeland A., Holme I., Leren P., Norum K. R. High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. Artery. 1979 Feb;5(2):170–181. [PubMed] [Google Scholar]
  16. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 5;276(1):34–contd. doi: 10.1056/NEJM196701052760107. [DOI] [PubMed] [Google Scholar]
  17. Gjone E. Familial lecithin:cholesterol acyltransferase deficiency--a clinical survey. Scand J Clin Lab Invest Suppl. 1974;137:73–82. [PubMed] [Google Scholar]
  18. Glomset J. A. Physiological role of lecithin-cholesterol acyltransferase. Am J Clin Nutr. 1970 Aug;23(8):1129–1136. doi: 10.1093/ajcn/23.8.1129. [DOI] [PubMed] [Google Scholar]
  19. Glueck C. J., Gartside P., Fallat R. W., Sielski J., Steiner P. M. Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia. J Lab Clin Med. 1976 Dec;88(6):941–957. [PubMed] [Google Scholar]
  20. Goldbourt U., Medalie J. H. High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol. 1979 Mar;109(3):296–308. doi: 10.1093/oxfordjournals.aje.a112683. [DOI] [PubMed] [Google Scholar]
  21. Goldstein J. L., Brown M. S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974 Aug 25;249(16):5153–5162. [PubMed] [Google Scholar]
  22. Goldstein J. L., Brown M. S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897–930. doi: 10.1146/annurev.bi.46.070177.004341. [DOI] [PubMed] [Google Scholar]
  23. Goldstein J. L., Schrott H. G., Hazzard W. R., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973 Jul;52(7):1544–1568. doi: 10.1172/JCI107332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  25. Hamilton R. L., Williams M. C., Fielding C. J., Havel R. J. Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J Clin Invest. 1976 Sep;58(3):667–680. doi: 10.1172/JCI108513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hazzard W. R., Bierman E. L. Aggravation of broad- disease (type 3 hyperlipoproteinemia) by hypothyroidism. Arch Intern Med. 1972 Dec;130(6):822–828. [PubMed] [Google Scholar]
  27. Herbert P. N., Forte T., Heinen R. J., Fredrickson D. S. Tangier disease: one explanation of lipid storage. N Engl J Med. 1978 Sep 7;299(10):519–521. doi: 10.1056/NEJM197809072991005. [DOI] [PubMed] [Google Scholar]
  28. Innerarity T. L., Mahley R. W., Weisgraber K. H., Bersot T. P. Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex. J Biol Chem. 1978 Sep 10;253(17):6289–6295. [PubMed] [Google Scholar]
  29. Ishikawa T., Fidge N., Thelle D. S., Førde O. H., Miller N. E. The Tromsø Heart Study: serum apolipoprotein AI concentration in relation to future coronary heart disease. Eur J Clin Invest. 1978 Jun;8(3):179–182. doi: 10.1111/j.1365-2362.1978.tb00832.x. [DOI] [PubMed] [Google Scholar]
  30. Jenkins P. J., Harper R. W., Nestel P. J. Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J. 1978 Aug 5;2(6134):388–391. doi: 10.1136/bmj.2.6134.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Johansson B. G., Medhus A. Increase in plasma alpha-lipoproteins in chronic alcoholics after acute abuse. Acta Med Scand. 1974 Apr;195(4):273–277. doi: 10.1111/j.0954-6820.1974.tb08137.x. [DOI] [PubMed] [Google Scholar]
  32. Langer T., Strober W., Levy R. I. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest. 1972 Jun;51(6):1528–1536. doi: 10.1172/JCI106949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mahley R. W., Innerarity T. L., Bersot T. P., Lipson A., Margolis S. Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol. Lancet. 1978 Oct 14;2(8094):807–809. doi: 10.1016/s0140-6736(78)92588-6. [DOI] [PubMed] [Google Scholar]
  34. McIntyre N. Plasma lipids and lipoproteins in liver disease. Gut. 1978 Jun;19(6):526–530. doi: 10.1136/gut.19.6.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
  36. Miller N. E., Nestel P. J., Clifton-Bligh P. Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man. Atherosclerosis. 1976 May-Jun;23(3):535–547. doi: 10.1016/0021-9150(76)90013-7. [DOI] [PubMed] [Google Scholar]
  37. Miller N. E. The evidence for the antiatherogenicity of high density lipoprotein in man. Lipids. 1978 Dec;13(12):914–919. doi: 10.1007/BF02533850. [DOI] [PubMed] [Google Scholar]
  38. Miller N. E., Thelle D. S., Forde O. H., Mjos O. D. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977 May 7;1(8019):965–968. doi: 10.1016/s0140-6736(77)92274-7. [DOI] [PubMed] [Google Scholar]
  39. Miller N. E., Weinstein D. B., Carew T. E., Koschinsky T., Steinberg D. Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts. J Clin Invest. 1977 Jul;60(1):78–88. doi: 10.1172/JCI108772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nakai T., Otto P. S., Kennedy D. L., Whayne T. F., Jr Rat high density lipoprotein subfraction (HDL3) uptake and catabolism by isolated rat liver parenchymal cells. J Biol Chem. 1976 Aug 25;251(16):4914–4921. [PubMed] [Google Scholar]
  41. Nikkilä E. A., Kaste M., Ehnholm C., Viikari J. Increase of serum high-density lipoprotein in phenytoin users. Br Med J. 1978 Jul 8;2(6130):99–99. doi: 10.1136/bmj.2.6130.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Olefsky J. M., Farquhar J. W., Reaven G. M. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med. 1974 Oct;57(4):551–560. doi: 10.1016/0002-9343(74)90006-0. [DOI] [PubMed] [Google Scholar]
  43. Patsch J. R., Gotto A. M., Jr, Olivercrona T., Eisenberg S. Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4519–4523. doi: 10.1073/pnas.75.9.4519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pearson T. A., Bulkley B. H., Achuff S. C., Kwiterovich P. O., Gordis L. The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol. 1979 Mar;109(3):285–295. doi: 10.1093/oxfordjournals.aje.a112682. [DOI] [PubMed] [Google Scholar]
  45. Pykälistö O. J., Smith P. H., Brunzell J. D. Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. J Clin Invest. 1975 Nov;56(5):1108–1117. doi: 10.1172/JCI108185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ragland J. B., Bertram P. D., Sabesin S. M. Identification of nascent high density lipoproteins containing arginine-rich protein in human plasma. Biochem Biophys Res Commun. 1978 Jan 13;80(1):81–88. doi: 10.1016/0006-291x(78)91107-5. [DOI] [PubMed] [Google Scholar]
  47. Rhoads G. G., Gulbrandsen C. L., Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med. 1976 Feb 5;294(6):293–298. doi: 10.1056/NEJM197602052940601. [DOI] [PubMed] [Google Scholar]
  48. Rössner S., Kjellin K. G., Mettinger K. L., Sidén A., Söderström C. E. Normal serum-cholesterol but low H.D.L.-cholesterol concentration in young patients with ischaemic cerebrovascular disease. Lancet. 1978 Mar 18;1(8064):577–579. doi: 10.1016/s0140-6736(78)91026-7. [DOI] [PubMed] [Google Scholar]
  49. Schaefer E. J., Jenkins L. L., Brewer H. B., Jr Human chylomicron apolipoprotein metabolism. Biochem Biophys Res Commun. 1978 Jan 30;80(2):405–412. doi: 10.1016/0006-291x(78)90691-5. [DOI] [PubMed] [Google Scholar]
  50. Shepherd J., Packard C. J., Patsch J. R., Gotto A. M., Jr, Taunton O. D. Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest. 1978 Jun;61(6):1582–1592. doi: 10.1172/JCI109078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sigurdsson G., Nicoll A., Lewis B. Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest. 1975 Dec;56(6):1481–1490. doi: 10.1172/JCI108229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sigurdsson G., Nicoll A., Lewis B. Metabolism of very low density lipoproteins in hyperlipidaemia: studies of apolipoprotein B kinetics in man. Eur J Clin Invest. 1976 Mar 31;6(2):167–177. doi: 10.1111/j.1365-2362.1976.tb00508.x. [DOI] [PubMed] [Google Scholar]
  53. Sigurdsson G., Nicoll A., Lewis B. The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia. Eur J Clin Invest. 1976 Mar 31;6(2):151–158. doi: 10.1111/j.1365-2362.1976.tb00506.x. [DOI] [PubMed] [Google Scholar]
  54. Utermann G., Jaeschke M., Menzel J. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett. 1975 Aug 15;56(2):352–355. doi: 10.1016/0014-5793(75)81125-2. [DOI] [PubMed] [Google Scholar]
  55. Zilversmit D. B. Role of triglyceride-rich lipoproteins in atherogenesis. Ann N Y Acad Sci. 1976;275:138–144. doi: 10.1111/j.1749-6632.1976.tb43348.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES